AzurRx BioPharma, Inc.
AZRXNASDAQHealthcare
$3.45
+$0.07(+2.07%)
Market Cap$3432760
P/E Ratio—
52W High$3.66
52W Low$3.38
AzurRx BioPharma, Inc. (AZRX) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · AZRX · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2020-12 | 2019-12 | 2018-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.04M | $0.00M | $0.00M | $0.00M | $0.00M |
| Cost of Revenue | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Margin %(computed) | 0.00% | — | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $0.93M | $0.90M | $5.89M | $8.68M | $4.99M |
| G&A Expenses | $5.50M | $14.72M | $7.29M | $6.06M | $8.24M |
| Total Operating Expenses | $6.43M | $15.62M | $26.43M | $14.74M | $13.43M |
| Operating Income | ($7.08M) | ($15.62M) | ($26.43M) | ($14.74M) | ($13.43M) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | ($0.49M) | $0.00M | $5.84M | $0.43M | $0.10M |
| Income Before Tax | ($6.55M) | ($18.06M) | ($32.67M) | ($15.18M) | ($13.53M) |
| Income Tax Expense | $0.00M | $0.00M | ($0.40M) | $0.00M | $0.00M |
| Net Income | ($6.55M) | ($18.06M) | ($32.67M) | ($15.18M) | ($13.53M) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-4.16 | $-5.33 | $-5.90 | $-6.77 | $-8.77 |
| Wtd Avg Shares | 1.62M | 3.43M | 5.53M | 2.24M | 1.54M |
| EBITDA | ($7.08M) | ($15.62M) | ($26.83M) | ($13.72M) | ($12.63M) |
| EBITDA Margin %(computed) | — | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more AzurRx BioPharma, Inc. data
About AzurRx BioPharma, Inc. (AZRX) Income Statement
AzurRx BioPharma, Inc. (AZRX) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, AZRX reported revenue of $0.00B, gross profit of $0.00B (gross margin 0.00%), and net income of ($0.01B) — a net profit margin of -18078.34%.
Frequently asked questions
AZRX · 4 questionsAzurRx BioPharma, Inc. (AZRX) reported revenue of $0.00B for 2025, up —% year-over-year.
AZRX revenueAZRX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09